Literature DB >> 24265329

Diagnosis of multiple primary lung cancer: a systematic review.

Xinying Xue1, Yuxia Liu, Lei Pan, Yong Wang, Kaifei Wang, Mingyue Zhang, Peilan Wang, Jianxin Wang.   

Abstract

A substantial percentage (8%) of all newly diagnosed cancer cases are in patients with previous tumours, with a similar trend in lung cancer. Cases of multiple primary lung cancer (MPLC) are increasing worldwide, due to improved diagnostic and surveillance mechanisms and the ageing population. Diagnosis of MPLC is complicated by difficulties in distinguishing it from lung cancer metastasis. Clinicopathological assessment, diagnosis and management have evolved, but remain severely limited by the lack of robust and dependable molecular markers for the differential diagnosis of metastasis and MPLC. This systematic review evaluates diagnostic criteria for MPLC, and the subsequent management and success rates. The incorporation of molecular biology techniques into the diagnostic process for MPLC is also discussed.

Entities:  

Keywords:  Multiple primary lung cancer; metachronous; nonsmall cell lung cancer; synchronous

Mesh:

Substances:

Year:  2013        PMID: 24265329     DOI: 10.1177/0300060513504707

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  14 in total

1.  Single-staged uniportal VATS major pulmonary resection for bilateral synchronous multiple primary lung cancers.

Authors:  Chengwu Liu; Lin Ma; Feng Lin; Jiandong Mei; Qiang Pu; Hu Liao; Chenglin Guo; Lunxu Liu
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

2.  Risk Stratification for Second Primary Lung Cancer.

Authors:  Summer S Han; Gabriel A Rivera; Martin C Tammemägi; Sylvia K Plevritis; Scarlett L Gomez; Iona Cheng; Heather A Wakelee
Journal:  J Clin Oncol       Date:  2017-06-23       Impact factor: 44.544

3.  Video-assisted thoracoscopic surgery: pneumonectomy for synchronous primary lung malignancies.

Authors:  Habiba Hashimi; David T Cooke; Sarah K Holmes; Lisa M Brown; Elizabeth A David
Journal:  J Vis Surg       Date:  2016-03-28

4.  Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report.

Authors:  Irene Vanni; Simona Coco; Silvia Bonfiglio; Davide Cittaro; Carlo Genova; Federica Biello; Marco Mora; Valeria Rossella; Maria Giovanna Dal Bello; Anna Truini; Barbara Banelli; Dejan Lazarevic; Angela Alama; Erika Rijavec; Giulia Barletta; Francesco Grossi
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

5.  Synchronous mucinous and non-mucinous lung adenocarcinomas with different epidermal growth mutational status.

Authors:  Rita Linhas; David Tente; Margarida Dias; Ana Barroso
Journal:  Respir Med Case Rep       Date:  2017-06-03

6.  Propensity score analysis of lung cancer risk in a population with high prevalence of non-smoking related lung cancer.

Authors:  Kuei-Feng Lin; Hsiu-Fu Wu; Wei-Chun Huang; Pei-Ling Tang; Ming-Ting Wu; Fu-Zong Wu
Journal:  BMC Pulm Med       Date:  2017-09-06       Impact factor: 3.317

7.  Different histological types of triple metachronous primary lung carcinomas in 1 patient: Case report.

Authors:  Jee Hyuk Kim; Seung Yong Park; Seoung Ju Park; Myoung Ja Chung; Heung Bum Lee
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

8.  A case of three synchronous primary lung cancers within the same lung lobe.

Authors:  Szymon Wcisło; Piotr Misiak; Marian Brocki
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-06-30

Review 9.  [Research Progress in Diagnosis and Management Strategies 
of Multiple Primary Lung Cancer].

Authors:  Haifa Guo; Yang Shen-Tu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-05-20

10.  Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.

Authors:  May Elbanna; Kevin Shiue; Donna Edwards; Alberto Cerra-Franco; Namita Agrawal; Jason Hinton; Todd Mereniuk; Christina Huang; Joshua L Ryan; Jessica Smith; Vasantha D Aaron; Heather Burney; Yong Zang; Jordan Holmes; Mark Langer; Richard Zellars; Tim Lautenschlaeger
Journal:  Clin Lung Cancer       Date:  2020-06-02       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.